University of Wisconsin School of Medicine and Public Health
Immune Checkpoint Inhibition and the Evolving Multidisciplinary Management of Head and Neck Cutaneous Squamous Cell Carcinoma. Brower JV, Amini A, Kirtane K, Harari PM, Chera BS, Caudell JJ.Pract Radiat Oncol. 2026 Aug 19:S1879-8500(26)00257-2. doi: 10.1016/j.prro.2026.07.005. Online ahead of print.PMID: 42617949 No abstract available. Monte carlo assessment of advanced shielding materials for space-efficient radiotherapy vault design. Koo B, …
Signaling Mutations Negate the Favorable Impact of NPM1 Mutations in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With VEN/HMA. Hoff FW, Zeidner JF, Torlapati G, Nicolet D, Mrózek K, Huang Y, Li A, Welkie RL, Swords RT, Traer E, Stein EM, Lin TL, Baer MR, Duong VH, Blum WG, Arellano ML, Stock W, …
Development and characterization of a 1-2 MeV electron beam platform with magnetic focusing and steering for shallow high-dose-rate irradiation. Huang J, Hu S, Mo C, Ye Y, Zhang T, Dai Z, Huang Y, Chen Y, Zheng J, Wang J, Bi Y.Phys Med Biol. 2026 Jun 30;71(13). doi: 10.1088/1361-6560/ae7cd3.PMID: 42285143 Class I HDAC inhibition enhances the stem-like …
Inhibition of autophagy increases head and neck cancer sensitivity to cetuximab and radiation therapy.Lee YS, Nickel KP, Bradley ST, Skiba JH, Eckers JC, Swick AD, Hu R, Iida M, Gurel Z, Wheeler DL, Kimple RJ.Sci Rep. 2026 May 28. doi: 10.1038/s41598-026-53573-6. Online ahead of print.PMID: 42209566 Free article. Stereoselective Phosphorylation of d-Ribose as a Driver of Life’s …
Priming versus propagating: distinct immune effects of alpha- versus beta-particle emitting radiopharmaceuticals when combined with immune checkpoint inhibition in mice.Kerr CP, Jin WJ, Liu P, Grudzinski JJ, Ferreira CA, Comas Rojas H, Oñate AJ, Kwon O, Hyun M, Bio Idrissou M, Welch Schwartz R, Vera JM, Clark PA, Adeniyi A, Takashima M, Erbe AK, Shea AG, …